Reusable processing equipment
The machine and compatible accessories required for the documented cycle.
For clinics
A clear route from assessment to first case.
Clinic adoption
Understand the clinical setup, equipment, supporting materials and professional support before making a purchasing decision.
Clinic readiness
Designed for an established professional environment.
Mytocel MSK is not a direct-to-consumer product. Adoption starts with appropriately qualified professionals, a suitable sterile setup, current documentation and a defined clinical-governance pathway.
01
Clinical leadership
A named qualified clinician responsible for selection, consent, procedure and follow-up.
02
Appropriate environment
A setting able to support the required sterile field, consumables and professional workflow.
03
Governed adoption
Current documentation, training, stock control, outcome collection and incident reporting.
The core configuration
What Actomed will help you define.
Single-use sterile devices
Rigeneracons® RS stock aligned to planned clinic activity.
Professional documentation
Protocol, quick guide, FAQs and supporting clinical information.
Training and first-case planning
A route appropriate to your team, experience and intended service.
Supporting clinical consumables
The supplied quick guide identifies the additional standard materials required for the documented workflow, including sterile-field materials, local anaesthetic, saline, syringes, needles and a dermal punch.
The adoption journey
Five decisions, in the right order.
The process is designed to answer clinical, operational and commercial questions before the clinic commits to first use.
Assess
Evidence, clinical fit and governance
Configure
Equipment, consumables and pricing
Prepare
Training, documentation and setup
Begin
First-case readiness and support
Continue
Supply, resources and feedback
Before ordering
Questions worth resolving early.
Actomed can help coordinate product and onboarding questions. Clinical decision-making and local governance remain with the treating organisation.
+Which clinicians will lead the service?
Identify the clinician responsible for case selection, consent, procedure delivery, follow-up and adverse-event governance.
+What activity do you expect?
An expected first-quarter case volume helps define equipment and single-use stock requirements.
+How will outcomes be recorded?
The internal material includes KOOS and feedback resources that can support a structured local outcomes pathway.
+Where will the procedure take place?
Confirm the clinical room, sterile workflow, supporting consumables and local policies before the first case.
+Are you supplying in Great Britain or Northern Ireland?
Different device-market rules apply. Confirm the intended territory during the pricing and onboarding discussion.
Professional enquiries
Plan your Mytocel MSK clinic setup.
Tell us about your service, intended start date and likely activity. Actomed will respond with the relevant UK configuration and next steps.